Page 5 - 《中国药房》2022年23期

CHINA PHARMACY

Volume 33，Number 23， December 15，2022

Semimonthly
Table of Contents

Expert consensus on risk prevention and control of multiple drug use in elderly patients with cardiovascular diseases
and neuropsychiatric diseases ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ Chinese Society of Clinical Pharmacy of Chinese Medical Association （2817）

Research on the current status of clinical trial supervision for tumor neoantigen vaccine in China ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ LIU Qiang，LU Mengqing，HU Hongguo，CHEN Liangjiang，YAO Wenbing （2826）
Investigation of the prescriptions of outpatient/emergency oral iron supplements in 8 children’s/maternity and

children’s hospitals of third-grade class A ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ LI Rongrong，LIU Qian，WANG Tingyu，SUN Yanyan （2831）
Study on protective effect and mechanism of Arisaema Cum Bile on acute liver injury induced by CCl4 in mice
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ SHI Congjing，
DENG Yafang，ZHANG Zhihong，LI Biao，SU Huilin，PENG Donghui，ZENG Yuanning，WANG Qiuhong （2835）
Study on mechanism of action of Fuke duanhongyin capsule on the improvement of dysfunctional uterine bleeding
in rats⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
HE Ying，LING Yonggen，ZHAO Hongqing，WU Mengyao，BAI Lu，CHEN Qian，ZHOU Haohan，WANG Yuhong （2840）
Study on pharmacological components and mechanism of Qingre huoxue decoction in improving myocardial
ischemia-reperfusion injury ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ LI Rui，JI Shuliang，
ZHANG Jiechun，SUN Zhizhong，YANG Xiaodan，LIU Yude，KUANG Zaoyuan，QING Lijin，WU Wei （2845）
Rapid identification of chemical constituents in Abrus cantoniensis Hance by UPLC-Q-TOF/MS combined with
UNIFI platform ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ GUO Zhonghui，
ZHENG Xueying，LIANG Jie，TAN Yong，QIN Chunping，GUO Jiacheng，LI Yaohua，WEI Zhiying，CHEN Kuikui （2852）
Study on the mechanism of Shilinqing granules preventing the formation of calcium oxalate kidney stones in rats
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ JIN Xiaoxiao，LI Weisheng，YANG Xiong，ZHENG Cong，HE Wenqiang （2858）
Study on myocardial injury of rats induced by yunaconitine through mitochondrial apoptosis pathway ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅ SITU Ying，CHENG Wanqiu，SHEN Zhibin，CHEN Yanfen，TANG Chunping，CHEN Cong，JIANG Tao （2864）
Study on improvement effects of Jinkui shenqi pills on polycystic ovary syndrome model rats and the mechanism
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ MA Liya，DU Jingwen，ZHANG Tong，ZU Zhaoxuan，GUO Shen，ZHAO Shen，ZHANG Minghao （2869）
Identification of the chemical composition of Xiaoshi granules and study on its potential mechanism of the
treatment of functional dyspepsia ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ YU Qiuxiang，LI Siyu，CHANG An，FENG Jiaxin，ZHANG Hui （2874）
Preparation and characterization of doxorubicin and siRNA co-loaded CLMSNs and study on anti-multidrug-
resistant tumor cells ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ ZHANG Mengwei，YANG Shuoye，YANG Yanan，WANG Zhenwei，QU Lingbo （2880）
Effects of the expression of serum SIRT1 on therapeutic efficacy of sodium valproate in the treatment of
epilepsy patients ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ YANG Yanping，HE Die，ZHOU Zhen，ZENG Qingfan，PENG Hongying，ZHAO Lixin，MA Dan （2886）
Risk factor analysis of linezolid-induced hyponatremia and the establishment of its nomogram model ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ QIN Yan，YE Yanrong，SHEN Yun，CHEN Zhe，SHENG Huijie，LI Xiaoyu，LYU Qianzhou （2891）
Effects of body weight on the efficacy and safety of oral anticoagulants for the prevention of VTE after hip and
knee arthroplasty： a meta-analysis ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ YUAN Yao，LI Xinyu，SHAN Xuefeng，QIU Feng （2895）
Indirect meta-analysis of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ WANG Jia，LI Shuyue，QU Suxin，WANG Hao，GE Weihong （2901）
KAP investigation and analysis of drug use safety risk of Sanjin tablets ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ YANG Yalei，LI Chunxiao，LING Xiao，WANG Panpan，MA Jing，ZHAO Ya，ZHENG Hongmei （2908）